Sentinal4D
1 known investors
Find your way into Sentinal4D
555 people in our graph share verified history with the Sentinal4D team — schools, employers, funds. One of them is your warm intro.
Charles Grummittunlockedknows Chris Bakal · together at The Institute of Cancer Research (overlapped)
×3knows the team · via Massachusetts Institute of Technology (MIT)
×3knows the team · via University of Toronto
×5knows the team · via Harvard Medical School
Sentinal4D develops interpretable machine learning tools for analyzing 3D and 4D cell morphology in drug discovery and mechanistic biology. PointMIL is a framework that classifies static 3D cell point clouds while providing point-level explanations of model predictions, enabling scientists to see where on the cell surface the model finds evidence for biological conclusions.
Founders & leadership
MD

Matt De VriesinCo-Founder and CTO
CB
Chris BakalinChief Executive OfficerChris Bakal trained in microbiology, cell signaling, and genetics under leading researchers including Julian Davies, Tony Pawson, and Norbert Perrimon, and studied computer science at MIT's CSAIL before co-founding Sentinal4D, an AI drug discovery platform. He is also a professor of cancer morphodynamics at the Institute of Cancer Research in London.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountpre-seedDec 2024 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Sentinal4D do?
- Sentinal4D develops interpretable machine learning tools for analyzing 3D and 4D cell morphology in drug discovery and mechanistic biology. PointMIL is a framework that classifies static 3D cell point clouds while providing point-level explanations of model predictions, enabling scientists to see where on the cell surface the model finds evidence for biological conclusions.
- Who founded Sentinal4D?
- Sentinal4D was founded by Matt De Vries.
- Who are Sentinal4D's investors?
- Sentinal4D's investors include Twin Path Ventures.


